Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years - PubMed (original) (raw)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years
Kevin A Matthews et al. Alzheimers Dement. 2019 Jan.
Abstract
Introduction: Alzheimer's disease and related dementias (ADRD) cause a high burden of morbidity and mortality in the United States. Age, race, and ethnicity are important risk factors for ADRD.
Methods: We estimated the future US burden of ADRD by age, sex, and race and ethnicity by applying subgroup-specific prevalence among Medicare Fee-for-Service beneficiaries aged ≥65 years in 2014 to subgroup-specific population estimates for 2014 and population projection data from the United States Census Bureau for 2015 to 2060.
Results: The burden of ADRD in 2014 was an estimated 5.0 million adults aged ≥65 years or 1.6% of the population, and there are significant disparities in ADRD prevalence among population subgroups defined by race and ethnicity. ADRD burden will double to 3.3% by 2060 when 13.9 million Americans are projected to have the disease.
Discussion: These estimates can be used to guide planning and interventions related to caring for the ADRD population and supporting caregivers.
Keywords: Alzheimer's disease; Dementia; Estimates; Prevalence; Projections; Race and ethnicity.
Published by Elsevier Inc.
Figures
Fig. 1.
Estimated prevalence of Alzheimer’s disease and related dementias in the US Population aged ≥65 years, by sex and race and ethnicity; United States, 2014.
Fig. 2.
Estimated prevalence of Alzheimer’s disease and related dementias in the US Population aged ≥65 years, by age and race and ethnicity; United States, 2014.
Fig. 3.
Projected number of adults aged ≥65 years with Alzheimer’s disease and related dementias for all groups (A), and by sex (B), age (C), and race and ethnicity (D); 2015 to 2060. Abbreviations: ADRD, Alzheimer’s disease and related dementia; AIAN, American Indian or Alaska Native; NH-White, Non-Hispanic white; PI, Pacific Islander.
Similar articles
- Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.
Barthold D, Joyce G, Ferido P, Drabo EF, Marcum ZA, Gray SL, Zissimopoulos J. Barthold D, et al. J Alzheimers Dis. 2020;76(2):579-589. doi: 10.3233/JAD-200133. J Alzheimers Dis. 2020. PMID: 32538845 Free PMC article. - The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer.
Schiaffino MK, Schumacher JR, Nalawade V, Nguyen PTN, Yakuta M, Gilbert PE, Dale W, Murphy JD, Moore AA. Schiaffino MK, et al. J Geriatr Oncol. 2023 Nov;14(8):101610. doi: 10.1016/j.jgo.2023.101610. Epub 2023 Sep 2. J Geriatr Oncol. 2023. PMID: 37666209 Free PMC article. - Alzheimer's disease and its related dementias in US Native Americans: A major public health concern.
Sehar U, Kopel J, Reddy PH. Sehar U, et al. Ageing Res Rev. 2023 Sep;90:102027. doi: 10.1016/j.arr.2023.102027. Epub 2023 Aug 5. Ageing Res Rev. 2023. PMID: 37544432 Free PMC article. Review. - Alzheimer's disease and Alzheimer's disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers.
Rawat P, Sehar U, Bisht J, Reddy AP, Reddy PH. Rawat P, et al. Ageing Res Rev. 2024 Jan;93:102178. doi: 10.1016/j.arr.2023.102178. Epub 2023 Dec 27. Ageing Res Rev. 2024. PMID: 38154509 Review.
Cited by
- Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions.
Zheng HT, Wu Z, Mielke MM, Murray AM, Ryan J. Zheng HT, et al. J Prev Alzheimers Dis. 2024;11(5):1189-1197. doi: 10.14283/jpad.2024.142. J Prev Alzheimers Dis. 2024. PMID: 39350363 Free PMC article. Review. - Pragmatic Clinical Trials for Dementia Care: Experience from the First 5 Years of the IMPACT Collaboratory.
Harrison J, Mitchell SL, McCarthy EP, Mor V. Harrison J, et al. Generations. 2024 Summer;48(2):00005. Epub 2024 Jun 26. Generations. 2024. PMID: 39347535 Free PMC article. - Alzheimer Dementia Among Individuals With Down Syndrome.
Rubenstein E, Tewolde S, Michals A, Weuve J, Fortea J, Fox MP, Pescador Jimenez M, Scott A, Tripodis Y, Skotko BG. Rubenstein E, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2435018. doi: 10.1001/jamanetworkopen.2024.35018. JAMA Netw Open. 2024. PMID: 39312235 Free PMC article. - Outdoor nighttime light exposure (light pollution) is associated with Alzheimer's disease.
Voigt RM, Ouyang B, Keshavarzian A. Voigt RM, et al. Front Neurosci. 2024 Sep 6;18:1378498. doi: 10.3389/fnins.2024.1378498. eCollection 2024. Front Neurosci. 2024. PMID: 39308948 Free PMC article. - Association between frailty index and cognitive dysfunction in older adults: insights from the 2011-2014 NHANES data.
Zhou J, Li Y, Zhu L, Yue R. Zhou J, et al. Front Aging Neurosci. 2024 Sep 5;16:1458542. doi: 10.3389/fnagi.2024.1458542. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39301115 Free PMC article.
References
- 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 2016; 12:459–509. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical